echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Immunother Cancer: Safety and effectiveness of immune checkpoint inhibitors in patients with previous psoriasis

    J Immunother Cancer: Safety and effectiveness of immune checkpoint inhibitors in patients with previous psoriasis

    • Last Update: 2021-11-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Immune checkpoint inhibitors (ICIS) block inhibitory T cell receptors and promote enhanced anti-tumor activity
    .


    These drugs, especially antibodies against CTLA-4, PD-1 and PD-L1 , have changed cancer treatments and have been approved for 15 different cancers


    , Has changed the method of cancer treatment, and has been approved for 15 different cancers


    In this retrospective cohort study, patients with previous psoriasis from 8 academic centers were evaluated and these patients received ICI for cancer


    In this multicenter study, ICI treatment was associated with frequent exacerbations of psoriasis, and the onset of psoriasis could be controlled by standard psoriasis treatment, and ICI was rarely discontinued
    .


    Therefore, patients with a history of psoriasis can receive ICI for malignant tumors


    Patients with a history of psoriasis can receive ICI for malignant tumors


    Literature source: Halle BR, Betof Warner A, Zaman FY, Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.